Antibiotice S.A. (BVB:ATB)

Market Cap	1.41B +1.0%
Revenue (ttm)	660.04M -4.2%
Net Income	51.77M -49.3%
EPS	0.08 -49.3%
Shares Out	671.34M
PE Ratio	27.23
Forward PE	n/a
Dividend	0.04 (1.81%)
Ex-Dividend Date	Oct 1, 2026

Volume	318,144
Average Volume	256,654
Open	2.090
Previous Close	2.095
Day's Range	2.045 - 2.100
52-Week Range	1.752 - 2.725
Beta	n/a
RSI	73.89
Earnings Date	May 27, 2026

About Antibiotice

Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company provides generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as well as cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; biocides for...

• Founded: 1955
• Employees: 1,356
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: ATB

Financial Performance

In 2025, Antibiotice's revenue was 660.04 million, a decrease of -4.16% compared to the previous year's 688.70 million. Earnings were 51.77 million, a decrease of -49.35%.